Testing alternative schedules of adjuvant immune checkpoint blockers - The need for well-designed clinical trials. (2023)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ejca.2022.10.024

PubMed Identifier: 36427393

Publication URI: http://europepmc.org/abstract/MED/36427393

Type: Journal Article/Review

Volume: 178

Parent Publication: European journal of cancer (Oxford, England : 1990)

ISSN: 0959-8049